Xuyu Zu

2.3k total citations
66 papers, 1.8k citations indexed

About

Xuyu Zu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xuyu Zu has authored 66 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 17 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Xuyu Zu's work include Epigenetics and DNA Methylation (15 papers), Cancer-related Molecular Pathways (8 papers) and Cancer-related gene regulation (8 papers). Xuyu Zu is often cited by papers focused on Epigenetics and DNA Methylation (15 papers), Cancer-related Molecular Pathways (8 papers) and Cancer-related gene regulation (8 papers). Xuyu Zu collaborates with scholars based in China, United States and Czechia. Xuyu Zu's co-authors include Jianghua Liu, Jing Zhong, Renxian Cao, Ge‐Bo Wen, Qinghai Zhang, Deliang Cao, Chunyan Tan, Jingsong Cao, Yuyang Jiang and Yingying Shen and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Clinical Cancer Research.

In The Last Decade

Xuyu Zu

65 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuyu Zu China	26	1.1k	515	320	201	164	66	1.8k
Changyan Chen United States	28	1.3k 1.2×	326 0.6×	389 1.2×	179 0.9×	168 1.0×	69	1.9k
Dong Joon Kim China	25	1.4k 1.2×	404 0.8×	320 1.0×	191 1.0×	118 0.7×	58	2.0k
Ke Yao United States	28	1.5k 1.3×	298 0.6×	389 1.2×	162 0.8×	175 1.1×	61	2.0k
Andréia Machado Leopoldino Brazil	23	989 0.9×	290 0.6×	262 0.8×	128 0.6×	108 0.7×	79	1.5k
Hui‐Chiu Chang Taiwan	31	1.3k 1.2×	453 0.9×	555 1.7×	138 0.7×	104 0.6×	52	2.4k
Miyong Yun South Korea	22	1.1k 0.9×	370 0.7×	300 0.9×	207 1.0×	135 0.8×	53	1.5k
Shih‐Hsin Tu Taiwan	22	1.1k 0.9×	308 0.6×	375 1.2×	124 0.6×	73 0.4×	68	1.7k
Niharika Nath United States	19	986 0.9×	240 0.5×	331 1.0×	332 1.7×	126 0.8×	39	1.9k
Michela Giuliano Italy	28	952 0.8×	297 0.6×	393 1.2×	114 0.6×	113 0.7×	84	1.9k

Countries citing papers authored by Xuyu Zu

Since Specialization

Citations

This map shows the geographic impact of Xuyu Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuyu Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuyu Zu more than expected).

Fields of papers citing papers by Xuyu Zu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuyu Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuyu Zu. The network helps show where Xuyu Zu may publish in the future.

Co-authorship network of co-authors of Xuyu Zu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuyu Zu. A scholar is included among the top collaborators of Xuyu Zu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuyu Zu. Xuyu Zu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Jiahao, et al.. (2024). 2011P Neoadjuvant immunotherapy-driven bladder preservation for muscle-invasive bladder cancer: A multicenter, propensity score-matched cohort study. Annals of Oncology. 35. S1160–S1160. 1 indexed citations

Wu, Weijun, Wenjing Wu, Qiao Yang, et al.. (2024). The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation. Journal of Biological Chemistry. 300(3). 105671–105671. 2 indexed citations

Chen, Xisha, et al.. (2024). ZBTB7A as a therapeutic target for cancer. Biochemical and Biophysical Research Communications. 736. 150888–150888.

Zeng, Zhaolin, Zhibo Zhao, Shiqi Yang, et al.. (2024). Hepatic Steatosis Aggravates Vascular Calcification via Extracellular Vesicle‐Mediated Osteochondrogenic Switch of Vascular Smooth Muscle Cells. Advanced Science. 12(5). e2408660–e2408660. 2 indexed citations

Xiang, Shasha, et al.. (2024). Role of ubiquitin-specific proteases in programmed cell death of breast cancer cells. Genes & Diseases. 12(3). 101341–101341. 1 indexed citations

Xiang, Shasha, et al.. (2023). Downregulated circPOKE promotes breast cancer metastasis through activation of the USP10-Snail axis. Oncogene. 42(44). 3236–3251. 12 indexed citations

Cao, Renxian, Gang Luo, Yu Li, et al.. (2023). FUNDC2, a mitochondrial outer membrane protein, mediates triple-negative breast cancer progression via the AKT/GSK3β/GLI1 pathway. Acta Biochimica et Biophysica Sinica. 55(11). 1770–1783. 1 indexed citations

Cao, Jingsong, Xuyu Zu, & Jianghua Liu. (2021). The roles of immune cells in atherosclerotic calcification. Vascular. 30(5). 902–913. 7 indexed citations

Chen, Ling, Xiaolin Zhong, Wenyu Cao, et al.. (2021). JQ1 as a BRD4 Inhibitor Blocks Inflammatory Pyroptosis-Related Acute Colon Injury Induced by LPS. Frontiers in Immunology. 12. 609319–609319. 39 indexed citations

10.

Zu, Xuyu, et al.. (2019). The absent in melanoma 2 (AIM2) inflammasome in microbial infection. Clinica Chimica Acta. 495. 100–108. 14 indexed citations

11.

Zhong, Jing, Yajun Chen, Ling Chen, et al.. (2017). PRMT2β, a C-terminal splice variant of PRMT2, inhibits the growth of breast cancer cells. Oncology Reports. 38(2). 1303–1311. 12 indexed citations

12.

He, Baoyu, Wei‐Ming Li, Yingfen Wu, et al.. (2016). Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103. Cell Death and Disease. 7(9). e2353–e2353. 123 indexed citations

13.

Zhong, Jing, Chang Liu, Yajun Chen, et al.. (2016). The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion. Journal of Translational Medicine. 14(1). 80–80. 30 indexed citations

14.

Ma, Jin, Ting Wang, Rui Guo, et al.. (2015). MicroRNA-133a and microRNA-326 co-contribute to hepatocellular carcinoma 5-fluorouracil and cisplatin sensitivity by directly targeting B-cell lymphoma-extra large. Molecular Medicine Reports. 12(4). 6235–6240. 12 indexed citations

15.

Shen, Yi, Jun Ma, Ruilan Yan, et al.. (2014). Impaired Self-Renewal and Increased Colitis and Dysplastic Lesions in Colonic Mucosa of AKR1B8-Deficient Mice. Clinical Cancer Research. 21(6). 1466–1476. 49 indexed citations

16.

Liu, Chuan, et al.. (2012). APE1 Asp148Glu gene polymorphism and bladder cancer risk: a meta-analysis. Molecular Biology Reports. 40(1). 171–176. 16 indexed citations

17.

Zhong, Jing, Renxian Cao, Jing Yang, et al.. (2011). Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer. Gene. 487(1). 1–9. 28 indexed citations

18.

Zu, Xuyu, Yiming Sun, Jing Tian, et al.. (2010). Global mapping of ZBTB7A transcription factor binding sites in HepG2 cells. Cellular & Molecular Biology Letters. 15(2). 260–71. 7 indexed citations

19.

Zu, Xuyu, Qinsheng Sun, Feng Liu, et al.. (2009). SP1 enhances Zbtb7A gene expression via direct binding to GC box in HePG2 cells. BMC Research Notes. 2(1). 175–175. 13 indexed citations

20.

Liu, Huachen, Aijun Dong, Chunmei Gao, et al.. (2008). The design, synthesis, and anti-tumor mechanism study of N-phosphoryl amino acid modified resveratrol analogues. Bioorganic & Medicinal Chemistry. 16(23). 10013–10021. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact